Dolutegravir-Lamivudine as Dual Therapy in Naive HIV-Infected Patients: A Pilot Study (PADDLE)

This study is currently recruiting participants. (see Contacts and Locations)
Verified March 2015 by The Huesped Foundation
Sponsor:
Collaborator:
ViiV Healthcare
Information provided by (Responsible Party):
Pedro Cahn, The Huesped Foundation
ClinicalTrials.gov Identifier:
NCT02211482
First received: August 5, 2014
Last updated: March 2, 2015
Last verified: March 2015
No Study Results Posted on ClinicalTrials.gov for this Study
  Study Status: This study is currently recruiting participants.
  Estimated Study Completion Date: April 2016
  Estimated Primary Completion Date: February 2016 (Final data collection date for primary outcome measure)